You are here

NAFLD Study Group Symposium: NAFLD: from mechanism to treatment

Wednesday, 23 September 2020, 12:00 - 13:30, Villach Hall

Chairs: Amalia Gastaldelli, IT; Paula Macedo, PT

Michele Vacca, UK: TGF/BMP signaling, stellate cells and NASH progression: is it just a matter of fat and scars? The BMP8B paradigm

Christopher Byrne, UK: The intestinal microbiome and NAFLD: is modification of the gut microbiota a therapeutic option?

Sven Francque, BE: Current and future pharmacological treatment options for NAFLD/NASH